Evaluation of hand-foot syndrome and hand-foot skin reaction: Case series
| Autor: | Basak Yalici Armagan, Hatice Gamze Demirdag, Burcu Tuğrul Ayanoğlu |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Orthodontics
multikinase inhibitors integumentary system business.industry Dermatology lcsh:RL1-803 chemotherapy lcsh:Diseases of the genitourinary system. Urology lcsh:RC870-923 Hand-Foot Syndrome Skin reaction Hand-foot syndrome hand-foot skin reaction lcsh:Dermatology Medicine skin and connective tissue diseases business Foot (unit) |
| Zdroj: | Türkderm, Vol 53, Iss 1, Pp 28-31 (2019) |
| ISSN: | 1308-6294 1019-214X |
| DOI: | 10.4274/turkderm.galenos.2018.98624 |
| Popis: | Hand-foot syndrome (palmoplantar erythrodysesthesia, palmar-plantar erythema, toxic erythema of the palms and soles, or Burgdorf’s syndrome) is characterized by painful predominantly palmoplantar lesions with the association of different chemotherapeutic agents. More recently, hand-foot skin reaction has been reported to be associated with regimens using targeted agents, in particular the multikinase inhibitors. Hand-foot syndrome/skin reaction has a major impact on patient’s quality of life, necessitating dose reduction or treatment interruption. In this article, hand-foot syndrome and hand-foot skin reaction were discussed through patients consulted our dermatology outpatient clinic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|